Private Placement

Vynleads launches its Done With Diabetes app, using AI for daily support. But can it stand out in a crowded market and reverse its financial fortunes?

Moody's affirms the Estonian energy giant's Baa3 rating, but a negative outlook signals deep-seated risks from its oil shale legacy and market volatility.

Publicly traded SUI Group launches its Ethena-backed synthetic dollar and a new yield vault, aiming to lure institutional capital to the Sui blockchain.

New patents protect Electra's radical blown-lift tech, paving a practical FAA certification path for its EL9 aircraft and challenging the eVTOL model.

QuickLogic will showcase an eFPGA chiplet on Intel's 18A process at Chiplet Summit 2026, signaling a new era of flexible, post-silicon hardware design.

Amidst sector uncertainty, Vision Ridge Partners' record $2.4B fundraise signals massive institutional confidence in sustainable real assets and climate solutions.

UCLA's Dr. Donald Kohn joins the Jeffrey Modell Foundation to discuss revolutionary gene therapies offering new hope for Primary Immunodeficiency patients.

SOFIE Biosciences' FAPI-PRO trial begins, testing a novel radiotracer that could revolutionize the detection of one of the deadliest forms of cancer.

With a new OTCQB listing, Pecoy Copper aims to unlock U.S. capital for its massive Peruvian project amid a looming global copper shortage.

The asset manager starts 2026 with a bang, fueled by massive European inflows, a strategic shift to higher-fee products, and resilient digital asset growth.

Echodyne is building a $40M facility to meet soaring global demand for advanced radar, aiming to counter drone threats and bolster U.S. manufacturing.

AI startup Inturai Ventures is arming North American forces with tech that sees through walls, securing a major deal that could reshape tactical surveillance.

Pharma veteran Pinder Sahota joins digital health firm Reset Health, signaling a strategic shift to integrated care in the new era of weight-loss drugs.

With French state backing, Eutelsat secures €1bn to build its next-gen OneWeb LEO constellation, intensifying the global satellite internet race.

Zelluna partners with Medpace for a first-in-human trial of its ZIMA-101 TCR-NK therapy, a new 'off-the-shelf' approach for hard-to-treat solid tumors.

With a 135% revenue surge and a key FDA submission for its kidney transplant drug, Hansa Biopharma is poised for a pivotal year of expansion.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

AI genomics firm partners with two major US health systems, aiming to accelerate cancer and rare disease diagnostics for 60,000 patients annually.

InspireSemi schedules a key shareholder update as its Thunderbird I chip, built on RISC-V, aims to challenge NVIDIA and AMD in the AI accelerator market.

The expanded credit facility provides fintech leader Upgrade with enhanced capital to scale its consumer lending platform, fueling its rapid market expansion.